arrow
M

Miriam Angeloni

friedrich- alexander-universität erlangen-nürnberg
H指数:7
被引数:288

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Landscape of Actionable Genetic Alterations in Advanced Urothelial Carcinoma: High Prevalence but Limited Clinical Use

晚期尿路上皮癌中可操作的遗传变异景观:高患病率但临床应用有限

2026-08-310
OAAI
Prognostic value of the tumor immune microenvironment, PD-L1 and p16INK4A in penile squamous cell carcinoma

阴茎鳞状细胞癌中肿瘤免疫微环境、PD-L1和p16INK4A的预后价值

2026-04-080
OAAI
Artificial intelligence in surgical disciplines: Clinical application, advantages, and potential-a Delphi expert consensus

人工智能在外科学科中的应用:临床应用、优势及潜力——德尔菲专家共识

2026-01-010
OAAI
Robust Consensus Molecular Subtyping of Muscle-Invasive Bladder Cancer Via 3' RNA Sequencing of Formalin-Fixed Paraffin-Embedded Tissues: Potential Impact for Clinical and Trial Settings

通过固定石蜡包埋组织的3' RNA测序实现稳健的肌层浸润性膀胱癌分子亚型分类:对临床和试验设置的潜在影响

2025-05-020
OAAI
Electrically Conductive Collagen-PEDOT:PSS Hydrogel Prevents Post-Infarct Cardiac Arrhythmia and Supports hiPSC-Cardiomyocyte Function

导电胶原蛋白-PEDOT:PSS水凝胶可防止梗死后心律失常并支持hiPSC-心肌细胞功能

2024-05-035
OAAI
A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing

从H & E载玻片预测上尿路尿路上皮癌蛋白亚型的深度学习工作流程,支持对患者进行分子检测的优先排序

2024-03-190
OAAI
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts
2024-01-0913
OAAI
Validation of the 'Inflammatory Bowel Disease-Distribution, Chronicity, Activity [IBD-DCA] Score' for Ulcerative Colitis and Crohn′s Disease
2021-03-2827
OAAI